Study details
Enrolling now
Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas
University of California, Davis
NCT IDNCT06389123ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1
Target enrollment
40
Study length
about 4 years
Ages
18+
Locations
1 site in CA
What this study is about
This trial is testing a new treatment, [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G, in people with metastatic cancer. The goal is to see if this treatment is safe and effective.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take [68Ga]Ga DOTA-5G and [177Lu]Lu DOTA-ABM-5G
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: [68Ga]Ga DOTA-5G PET/CT imaging